A new frontier for medical device trust and patient safety

Tern plc

As clinical environments become increasingly digital and interconnected, medical devices no longer operate in isolation. They link into hospital networks, share data across platforms, interface with cloud services and increasingly fall under regulatory scrutiny. That means the device manufacturers and healthcare providers face new challenges, including how to establish trust, how to manage devices through their lifecycle, and how to ensure compliance with evolving standards. Device Authority’s KeyScaler platform presents itself as a technology to address exactly these challenges in the realm of the Internet of Medical Things (IoMT).

At a fundamental level the platform begins with device trust. Each device must be registered, authenticated and clearly identified before it transmits patient data or interfaces with clinical systems. Once that trust anchor is in place, KeyScaler automates credential issuance and lifecycle management so that as devices are deployed, maintained, updated or retired the identity and certificate infrastructure is managed at scale.

Connected devices are generating streams of sensitive patient information, system telemetry and operational metrics. Encryption, secure updates and policy‑driven access become mandatory. The KeyScaler platform emphasises end‑to‑end encryption, including the ability to manage data both at rest and in transit, and to enforce policies on how and when keys can be used.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc issues 78.2m shares following Open Offer

Tern Plc announced valid acceptances for 78,163,662 Open Offer Shares at 0.40 pence per share, generating gross proceeds of about £312,654. The enlarged share capital will total 750,877,367 ordinary shares upon admission to AIM.

Fundamental XR expands access to immersive training with web-enabled platform

Its new Immersive Web platform brings immersive training into the browser, lowering adoption barriers and broadening enterprise reach.

GLP-1 receptor agonists: Strategic market shift

Rapid uptake, evolving regulation and digital integration are reshaping the investment case for metabolic health therapies.

The Cyber Resilience Act forces a security reset for connected device makers

Device Authority helps manufacturers operationalise Cyber Resilience Act compliance through automated device identity and secure update management.

Pharmaceutical groups move closer to the consumer in strategic marketing reset

Pharmaceutical marketing is shifting towards direct consumer engagement, reshaping how companies compete and manage risk in a digital environment.

Changing clinician behaviour reshapes commercial strategy for 2026

As clinician engagement becomes more digital and measurable, companies that act on behavioural data can improve targeting, reduce risk and strengthen competitive positioning in 2026.

Search

Search